HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) A correction has been published Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Larousserie, F. Articles by Devergne, O. Search for Related Content PubMed PubMed Citation Articles by Larousserie, F. Articles by Devergne, O.

Differential Effects of IL-27 on Human B Cell Subsets¹

Frédérique Larousserie^2,*, Pascaline Charlot^2,*, Emilie Bardel^*, Josy Froger, Robert A. Kastelein and Odile Devergne^3,*

^* Centre National de la Recherche Scientifique, Unité Mixte de Recherche 8147, Université Paris V, Institut Fédératif de Recherche Necker, Paris, France; Institut National de la Santé et de la Recherche Médicale, Unité 564, Angers, France; and Schering-Plough Biopharma (formerly DNAX), Palo Alto, CA 94304

IL-27 is a novel heterodimeric cytokine of the IL-12 family that plays an important role in the regulation of T cell responses. Its role on human B cells has not been previously studied. In this study, we show that both chains of the IL-27 receptor complex, IL-27R and gp130, are constitutively expressed at the surface of naive and memory human tonsillar B cells, and are induced on germinal center B cells following CD40 stimulation. In naive B cells, IL-27 induced strong STAT1 and STAT3 phosphorylation, whereas it induced moderate STAT1 and low STAT3 activation in memory B cells. IL-27 induced T-bet expression in naive and memory B cells stimulated by CD40 or surface Ig engagement, but induced significant IL-12R2 surface expression in anti-Ig-stimulated naive B cells only. In anti-Ig-stimulated naive or memory B cells, IL-27 also induced CD54, CD86, and CD95 surface expression. In addition, IL-27 increased proliferation of anti-Ig-activated naive B cells and of anti-CD40-activated naive and germinal center B cells, but not of CD40-activated memory B cells. These data indicate that the B cell response to IL-27 is modulated during B cell differentiation and varies depending on the mode of B cell activation.

This article has been cited by other articles:

				M. Matsui, T. Kishida, H. Nakano, K. Yoshimoto, M. Shin-Ya, T. Shimada, S. Nakai, J. Imanishi, T. Yoshimoto, Y. Hisa, et al. Interleukin-27 Activates Natural Killer Cells and Suppresses NK-Resistant Head and Neck Squamous Cell Carcinoma through Inducing Antibody-Dependent Cellular Cytotoxicity Cancer Res., March 15, 2009; 69(6): 2523 - 2530. [Abstract] [Full Text] [PDF]

				E. Bardel, F. Larousserie, P. Charlot-Rabiega, A. Coulomb-L'Hermine, and O. Devergne Human CD4+CD25+Foxp3+ Regulatory T Cells Do Not Constitutively Express IL-35 J. Immunol., November 15, 2008; 181(10): 6898 - 6905. [Abstract] [Full Text] [PDF]

				A. Pradhan, Q. T. Lambert, and G. W. Reuther Transformation of hematopoietic cells and activation of JAK2-V617F by IL-27R, a component of a heterodimeric type I cytokine receptor PNAS, November 20, 2007; 104(47): 18502 - 18507. [Abstract] [Full Text] [PDF]